Pérez-García JM - Search Results

1

3-year invasive disease-free survival with chemotherapy de-escalation using an ¹⁸F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.

Pérez-García JM, Cortés J, Ruiz-Borrego M, Colleoni M, Stradella A, Bermejo B, Dalenc F, Escrivá-de-Romaní S, Calvo Martínez L, Ribelles N, Marmé F, Cortés A, Albacar C, Gebhart G, Prat A, Kerrou K, Schmid P, Braga S, Di Cosimo S, Gion M, Antonarelli G, Popa C, Szostak E, Alcalá-López D, Gener P, Rodríguez-Morató J, Mina L, Sampayo-Cordero M, Llombart-Cussac A; PHERGain Trial Investigators. Pérez-García JM, et al. Lancet. 2024 Apr 27;403(10437):1649-1659. doi: 10.1016/S0140-6736(24)00054-0. Epub 2024 Apr 3. Lancet. 2024. PMID: 38582092 Clinical Trial.

2

Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors.

Vilar E, Salazar R, Pérez-García J, Cortes J, Oberg K, Tabernero J. Vilar E, et al. Endocr Relat Cancer. 2007 Jun;14(2):221-32. doi: 10.1677/ERC-06-0074. Endocr Relat Cancer. 2007. PMID: 17639039 Review.

3

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.

Muñoz-Couselo E, Pérez-García J, Cortés J. Muñoz-Couselo E, et al. Onco Targets Ther. 2011;4:185-92. doi: 10.2147/OTT.S16392. Epub 2011 Nov 14. Onco Targets Ther. 2011. PMID: 22162924 Free PMC article.

4

Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?

Pérez-García J, Cortés J. Pérez-García J, et al. Breast Cancer Res. 2012 Jan 26;14(1):104. doi: 10.1186/bcr3093. Breast Cancer Res. 2012. PMID: 22297134 Free PMC article.

5

A roadmap for accelerated drug approval in breast cancer?

Perez-Garcia J, Cortes J. Perez-Garcia J, et al. Lancet Oncol. 2012 Sep;13(9):850-1. doi: 10.1016/S1470-2045(12)70367-4. Epub 2012 Aug 9. Lancet Oncol. 2012. PMID: 22884504 No abstract available.

6

The effect of biology in the treatment of small breast tumors.

Perez-Garcia J, Muñoz-Couselo E, Cortes J. Perez-Garcia J, et al. Am Soc Clin Oncol Educ Book. 2013:25-31. doi: 10.14694/EdBook_AM.2013.33.25. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714447 Free article.

7

Adjuvant bevacizumab: positive data from a negative trial.

Perez-Garcia J, Cortes J. Perez-Garcia J, et al. Lancet Oncol. 2013 Sep;14(10):910-1. doi: 10.1016/S1470-2045(13)70378-4. Epub 2013 Aug 7. Lancet Oncol. 2013. PMID: 23932547 No abstract available.

8

New approach to cancer therapy based on a molecularly defined cancer classification.

Cortés J, Calvo E, Vivancos A, Perez-Garcia J, Recio JA, Seoane J. Cortés J, et al. CA Cancer J Clin. 2014 Jan-Feb;64(1):70-4. doi: 10.3322/caac.21211. Epub 2013 Nov 18. CA Cancer J Clin. 2014. PMID: 24249308 Free article. Review.

9

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors.

Dienstmann R, Rodon J, Prat A, Perez-Garcia J, Adamo B, Felip E, Cortes J, Iafrate AJ, Nuciforo P, Tabernero J. Dienstmann R, et al. Ann Oncol. 2014 Mar;25(3):552-563. doi: 10.1093/annonc/mdt419. Epub 2013 Nov 20. Ann Oncol. 2014. PMID: 24265351 Free PMC article. Review.

10

Therapeutic antibodies in breast cancer.

Pérez-Garcia J, Muñoz-Couselo E, Cortés J, Scaltriti M. Pérez-Garcia J, et al. Semin Oncol. 2014 Oct;41(5):576-88. doi: 10.1053/j.seminoncol.2014.07.002. Epub 2014 Jul 21. Semin Oncol. 2014. PMID: 25440604 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page